Repurposing of lonafarnib as a treatment for SARS-CoV-2 infection.
Khan M, Irvin P, Park SB, Ivester HM, Ricardo-Lax I, Leek M, Grieshaber A, Jang ES, Coutermarsh-Ott S, Zhang Q, Maio N, Jiang JK, Li B, Huang W, Wang AQ, Xu X, Hu Z, Zheng W, Ye Y, Rouault T, Rice C, Allen IC, Liang TJ.
Khan M, et al. Among authors: park sb.
JCI Insight. 2025 Jan 9;10(1):e182704. doi: 10.1172/jci.insight.182704.
JCI Insight. 2025.
PMID: 39625789
Free article.